Veritable’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-2,434
| Closed | -$532K | – | 630 |
|
2023
Q2 | $532K | Buy |
2,434
+8
| +0.3% | +$1.75K | 0.01% | 521 |
|
2023
Q1 | $531K | Buy |
2,426
+10
| +0.4% | +$2.19K | 0.01% | 512 |
|
2022
Q4 | $503K | Sell |
2,416
-116
| -5% | -$24.1K | 0.01% | 532 |
|
2022
Q3 | $553K | Buy |
2,532
+36
| +1% | +$7.86K | 0.01% | 469 |
|
2022
Q2 | $523K | Sell |
2,496
-173
| -6% | -$36.3K | 0.01% | 525 |
|
2022
Q1 | $647K | Sell |
2,669
-26
| -1% | -$6.3K | 0.01% | 493 |
|
2021
Q4 | $702K | Buy |
2,695
+32
| +1% | +$8.34K | 0.01% | 475 |
|
2021
Q3 | $702K | Buy |
2,663
+132
| +5% | +$34.8K | 0.01% | 461 |
|
2021
Q2 | $624K | Sell |
2,531
-26
| -1% | -$6.41K | 0.01% | 485 |
|
2021
Q1 | $496K | Sell |
2,557
-382
| -13% | -$74.1K | 0.01% | 510 |
|
2020
Q4 | $625K | Sell |
2,939
-117
| -4% | -$24.9K | 0.01% | 444 |
|
2020
Q3 | $524K | Buy |
3,056
+29
| +1% | +$4.97K | 0.01% | 451 |
|
2020
Q2 | $581K | Sell |
3,027
-260
| -8% | -$49.9K | 0.01% | 436 |
|
2020
Q1 | $484K | Buy |
3,287
+183
| +6% | +$26.9K | 0.01% | 455 |
|
2019
Q4 | $481K | Buy |
3,104
+130
| +4% | +$20.1K | 0.01% | 537 |
|
2019
Q3 | $402K | Buy |
2,974
+53
| +2% | +$7.16K | 0.01% | 566 |
|
2019
Q2 | $356K | Sell |
2,921
-39
| -1% | -$4.75K | 0.01% | 595 |
|
2019
Q1 | $308K | Buy |
2,960
+592
| +25% | +$61.6K | 0.01% | 634 |
|
2018
Q4 | $270K | Buy |
+2,368
| New | +$270K | 0.01% | 625 |
|
2013
Q4 | – | Sell |
-4,323
| Closed | -$228K | – | 992 |
|
2013
Q3 | $228K | Buy |
+4,323
| New | +$228K | 0.01% | 810 |
|